General DeepLCP model for disease prediction : Case of Lung Cancer
This addresses the critical issue of early disease prediction for patients at risk of fatal conditions, though it appears incremental as it builds on existing machine learning and NLP techniques.
The authors tackled the problem of late-stage disease detection by proposing DeepLCP, a model combining NLP and deep learning to predict fatal diseases like lung cancer from raw, heterogeneous data, achieving high accuracy and low loss rates in validation.
According to GHO (Global Health Observatory (GHO), the high prevalence of a large variety of diseases such as Ischaemic heart disease, stroke, lung cancer disease and lower respiratory infections have remained the top killers during the past decade. The growth in the number of mortalities caused by these disease is due to the very delayed symptoms'detection. Since in the early stages, the symptoms are insignificant and similar to those of benign diseases (e.g. the flu ), and we can only detect the disease at an advanced stage. In addition, The high frequency of improper practices that are harmful to health, the hereditary factors, and the stressful living conditions can increase the death rates. Many researches dealt with these fatal disease, and most of them applied advantage machine learning models to deal with image diagnosis. However the drawback is that imagery permit only to detect disease at a very delayed stage and then patient can hardly be saved. In this Paper we present our new approach "DeepLCP" to predict fatal diseases that threaten people's lives. It's mainly based on raw and heterogeneous data of the concerned (or under-tested) person. "DeepLCP" results of a combination combination of the Natural Language Processing (NLP) and the deep learning paradigm.The experimental results of the proposed model in the case of Lung cancer prediction have approved high accuracy and a low loss data rate during the validation of the disease prediction.